Reviewing Oscar Health (NYSE:OSCR) & Hippo (NYSE:HIPO)

Oscar Health (NYSE:OSCR) and Hippo (NYSE:HIPO) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Risk and Volatility

Oscar Health has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, Hippo has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500.

Earnings and Valuation

This table compares Oscar Health and Hippo”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.29 billion	0.32	$25.43 million	($1.12)	-12.02
Hippo	$450.10 million	1.81	-$40.50 million	$3.62	8.90

Oscar Health has higher revenue and earnings than Hippo. Oscar Health is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 43.0% of Hippo shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by insiders. Comparatively, 10.8% of Hippo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Oscar Health and Hippo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oscar Health	-2.16%	-21.50%	-4.28%
Hippo	21.30%	-5.89%	-1.28%

Analyst Ratings

This is a summary of current ratings and target prices for Oscar Health and Hippo, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	5	6	0	0	1.55
Hippo	1	1	4	1	2.71

Oscar Health currently has a consensus price target of $13.14, suggesting a potential downside of 2.36%. Hippo has a consensus price target of $35.50, suggesting a potential upside of 10.20%. Given Hippo’s stronger consensus rating and higher possible upside, analysts plainly believe Hippo is more favorable than Oscar Health.

Summary

Hippo beats Oscar Health on 10 of the 15 factors compared between the two stocks.

About Oscar Health

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

About Hippo

Hippo Holdings Inc. provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products. The company distributes insurance products and services through its technology platform and website, as well as operates licensed insurance agencies. Hippo Holdings Inc. is headquartered in Palo Alto, California.